Roche launches newborn screening test for three severe genetic conditions

Roche launches newborn screening test for three severe genetic conditions (RHHBY:OTCMKTS)

Roche’s TIB MOLBIOL launches CE-marked LightMix Newborn screening test for SMA, SCID & SCD—IVDR-approved and workflow-ready.

Roche launches newborn screening test for three severe genetic conditions

This test expands Roche's early diagnostics portfolio by screening for Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency Disease (SCID), and Sickle Cell Disease (SCD) simultaneously.Catching these conditions shortly after birth empowers clinicians to choose life-changing treatments sooner, before irreversible symptoms…